SCHEMBL6026151

SCHEMBL6026151

Nc1nc(NCc2ccccn2)nc(Cl)c1N

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 3/20 0.51
MAOB P27338 3/20 0.51
PLAU P00749 2/20 0.48
ADORA2A P29274 3/20 0.47
ADORA2B P29275 2/20 0.47
ADORA1 P30542 2/20 0.47
ADORA3 P0DMS8 1/20 0.47
KDM4E B2RXH2 2/20 0.44
HPGD P15428 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
NPC1 O15118 1/20 0.44
TP53 P04637 1/20 0.44
HTT P42858 1/20 0.44
RAB9A P51151 1/20 0.44
HSD17B10 Q99714 1/20 0.44
KCNH2 Q12809 2/20 0.44
ATAD2 Q6PL18 1/20 0.44
SUMO3 P55854 1/20 0.43
SUMO2 P61956 1/20 0.43
SUMO1 P63165 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21814659 0.79 APP (0.36) PLAU
SCHEMBL6024935 0.78 APP (0.59) ADORA2AADORA2BADORA1ADORA3
SCHEMBL3396367 0.78 PLAU (0.53) MAOAMAOBPLAUADORA2AADORA1
SCHEMBL1310429 0.78 MAOA (0.58) MAOAMAOBADORA2AADORA1KDM4E
SCHEMBL27609444 0.78 MAOA (0.60) MAOAMAOBADORA2AADORA2BADORA1
SCHEMBL15200781 0.77 PDE10A (0.51) MAOAMAOBADORA2AADORA2BKDM4E
SCHEMBL3556495 0.76 MAOA (0.56) MAOAMAOBADORA2AADORA1KDM4E
SCHEMBL8114510 0.75 BCHE (0.56) MAOAMAOBPLAUKDM4EHPGD
SCHEMBL10874371 0.73 KDM4C (0.59) MAOAMAOBPLAUKDM4EHPGD
SCHEMBL18207415 0.73 PPARG (0.51) MAOAMAOBPLAUKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1670802-A2 NOVEL HETEROCYCLIC COMPOUNDS AS HSP90-INHIBITORS Conforma Therapeutic Corporation (US) 2006-06-21 EP disclosed
WO-2005028434-A2 NOVEL HETEROCYCLIC COMPOUNDS AS HSP90-INHIBITORS CONFORMA THERAPEUTICS CORPORATION (US) 2005-03-31 WO disclosed